BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37477102)

  • 1. Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis.
    Lee D; Kim YN; Cho SH; Yoon HS; Kim YT; Kim S; Kim SW
    J Gynecol Oncol; 2023 Nov; 34(6):e79. PubMed ID: 37477102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
    Goncalves BT; Dos Reis R; Ribeiro R; Moretti-Marques R; Schamme FK; Oliveira GS; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Pastore CBP; Kumagai LY; Faloppa CC; Mantoan H; Badiglian-Filho L; De Brot L; Andrade CEMC; Baiocchi G
    Int J Gynecol Cancer; 2023 Oct; 33(10):1548-1556. PubMed ID: 37699707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity.
    Matanes E; Eisenberg N; Amajoud Z; Gupta V; Yasmeen A; Ismail S; Racovitan F; Raban O; Lau S; Salvador S; Gotlieb WH; Kogan L
    J Obstet Gynaecol Can; 2021 Oct; 43(10):1136-1144.e1. PubMed ID: 33984524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
    Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
    J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
    Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
    Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of comorbidities and extent of lymphadenectomy on quality of life in endometrial cancer patients treated with minimally invasive surgery in the era of sentinel lymph nodes.
    Dinoi G; Multinu F; Yost K; AlHilli M; Larish A; Langstraat C; Kumar A; Weaver AL; McGree M; Cheville A; Dowdy S; Mariani A; Glaser G
    Int J Gynecol Cancer; 2023 Aug; 33(8):1227-1236. PubMed ID: 37419517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The added value of sentinel node mapping in endometrial cancer.
    Kogan L; Matanes E; Wissing M; Mitric C; How J; Amajoud Z; Abitbol J; Yasmeen A; López-Ozuna V; Eisenberg N; Lau S; Salvador S; Gotlieb WH
    Gynecol Oncol; 2020 Jul; 158(1):84-91. PubMed ID: 32349874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
    Leitao MM; Zhou QC; Gomez-Hidalgo NR; Iasonos A; Baser R; Mezzancello M; Chang K; Ward J; Chi DS; Long Roche K; Sonoda Y; Brown CL; Mueller JJ; Gardner GJ; Jewell EL; Broach V; Zivanovic O; Dowdy SC; Mariani A; Abu-Rustum NR
    Gynecol Oncol; 2020 Jan; 156(1):147-153. PubMed ID: 31780238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
    Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
    Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
    Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer.
    Makroum AA; Lee YJ; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
    J Obstet Gynaecol Res; 2023 Aug; 49(8):2118-2125. PubMed ID: 37286510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical and oncological outcomes of sentinel lymph node sampling in elderly patients with intermediate to high-risk endometrial carcinoma.
    Matanes E; Eisenberg N; Mitric C; Yasmeen A; Ismail S; Raban O; Cantor T; Knigin D; Lau S; Salvador S; Gotlieb W; Kogan L
    Int J Gynecol Cancer; 2022 Jul; 32(7):875-881. PubMed ID: 35680137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
    Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
    Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.